NASDAQ: FBLG
Fibrobiologics Inc Stock Ownership - Who owns Fibrobiologics?

Insider buying vs selling

Have Fibrobiologics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Hamid KhojaChief Scientific Officer2025-05-2720,000$0.84
$16.80kBuy

1 of 1

FBLG insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FBLG insiders and whales buy or sell their stock.

FBLG Shareholders

What type of owners hold Fibrobiologics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pete Oheeron11.48%5,906,647$1.98MInsider
Vanguard Group Inc2.40%1,233,781$414.55kInstitution
Blackrock Inc0.85%439,773$147.76kInstitution
Cascade Financial Partners LLC0.58%298,081$100.16kInstitution
Geode Capital Management LLC0.56%288,948$97.09kInstitution
Cerity Partners LLC0.24%125,919$42.31kInstitution
Optivise Advisory Services LLC0.21%110,100$36.99kInstitution
Requisite Capital Management LLC0.21%109,713$36.86kInstitution
Richard C. Cilento Jr.0.18%93,225$31.32kInsider
American Institute For Advanced Investment Management LLP0.17%88,206$29.64kInstitution

1 of 3

FBLG vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FBLG5.72%11.78%Net Buying
LSTA0.66%99.34%Net Selling
HOTH2.44%52.08%Net SellingNet Selling
CASI0.16%99.84%
SYBX0.25%99.75%Net SellingNet Selling

Fibrobiologics Stock Ownership FAQ

Who owns Fibrobiologics?

Fibrobiologics (NASDAQ: FBLG) is owned by 5.72% institutional shareholders, 11.78% Fibrobiologics insiders, and 82.50% retail investors. Pete Oheeron is the largest individual Fibrobiologics shareholder, owning 5.91M shares representing 11.48% of the company. Pete Oheeron's Fibrobiologics shares are currently valued at $2.17M.

If you're new to stock investing, here's how to buy Fibrobiologics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.